Artificial intelligence in drug discovery: combining clinical and genomic data from cancer patients to identify genetic biomarkers and potential novel targets

Congress, Drug discovery, R&D, TopaziumLeave a comment

Drug discovery is a costly process affected by a high attrition rate. The huge investment from pharma industry in past years has generated a vast wealth of information in the field that constitutes a great opportunity if it is conveniently exploited. Topazium is a company fully committed to creating a new collective intelligence that enables…

Finding a needle in a haystack: virtual screening, an artificial intelligence approach to drug discovery

Drug discovery, Medicine, Publications, R&D, TopaziumLeave a comment

Artificial intelligence (AI) is a technology well suited for dealing with large amounts of information and has long been considered a promising tool in drug discovery. It has made steady in roads in the field in the last decade by improving the probability of success and bringing greater precision, speed, and cost-efficiency to a process…

Harnessing the power of AI and HTE, cloud lab and automation data to transform drug discovery

Drug discovery, Publications, R&D, TopaziumLeave a comment

Drug discovery is a lengthy and costly process affected by a high attrition rate. The revolution in experimental sciences brought about by HTE, cloud labs and lab automation should represent an excellent opportunity to completely transform drug discovery and overcome the serious problems that hinder the process. But this transformation will not be possible without…